Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Hepatocellular Carcinoma (HCC)”

693 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 693 results

Not applicableLooking for participantsNCT06794073
What this trial is testing

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Who this might be right for
Carcinoma, HepatocellularNeoplasms, Glandular and EpithelialAdenocarcinoma+2 more
Shanghai Zhongshan Hospital 17
Testing effectiveness (Phase 2)UnknownNCT04913480
What this trial is testing

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The University of Hong Kong 37
Not applicableUnknownNCT03881501
What this trial is testing

Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Huazhong University of Science and Technology 2
Not applicableStudy completedNCT05667064
What this trial is testing

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Who this might be right for
Unresectable Hepatocellular Carcinoma
AstraZeneca 1,200
Post-approval studies (Phase 4)Study completedNCT00829465
What this trial is testing

Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 400
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Testing effectiveness (Phase 2)Study completedNCT00807300
What this trial is testing

Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Magdeburg 77
Not applicableLooking for participantsNCT06788353
What this trial is testing

Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma

Who this might be right for
Transarterial ChemoembolizationSystemic TherapyUnresectable Hepatocellular Carcinoma
Sun Yat-sen University 500
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00077142
What this trial is testing

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 37
Large-scale testing (Phase 3)UnknownNCT01438450
What this trial is testing

Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
All India Institute of Medical Sciences 74
Testing effectiveness (Phase 2)Study completedNCT00083226
What this trial is testing

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 42
Early research (Phase 1)UnknownNCT05281926
What this trial is testing

A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 10
Not applicableUnknownNCT03807947
What this trial is testing

Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
Humanitas Clinical and Research Center 74
Not applicableUnknownNCT05114148
What this trial is testing

Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
UMC Utrecht 30
Testing effectiveness (Phase 2)Study completedNCT05532319
What this trial is testing

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC

Who this might be right for
Liver Cancer
Guangxi Medical University 64
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Looking for participantsNCT05440708
What this trial is testing

TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated 193
Testing effectiveness (Phase 2)Study completedNCT00867750
What this trial is testing

SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sirtex Medical 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841185
What this trial is testing

Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech 656
Next Page